Keenova Therapeutics to Report First Quarter 2026 Financial Results on May 12, 2026
B DUBLIN, April 30, 2026 /PRNewswire/ — Keenova Therapeutics plc, a leading developer and manufacturer of branded therapeutics, announced today that it will report its first… Login to continue reading Login Sign up for complimentary access Sign Up Now Close
CytoSorbents to Report First Quarter 2026 Financial Results and Recent Business Highlights
B PRINCETON, N.J., April 30, 2026 /PRNewswire/ — CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit… Login to continue reading Login Sign up for complimentary access Sign Up Now Close
GameAbove Golf Among Lead Investors in McLaren Golf, Expands Strategic Position in the Global Premium Golf Equipment Market
B Investment reinforces GameAbove’s long-term commitment to performance-driven innovation in global golf FORT MYERS, Fla., April 30, 2026 /PRNewswire/ — GameAbove Golf today announced it… Login to continue reading Login Sign up for complimentary access Sign Up Now Close
SiriusXM Reports First Quarter 2026 Operating and Financial Results
B NEW YORK, April 30, 2026 /PRNewswire/ — SiriusXM (NASDAQ: SIRI) today announced its operating and financial results for the first quarter 2026. The full… Login to continue reading Login Sign up for complimentary access Sign Up Now Close
X Financial Files Annual Report on Form 20-F for Fiscal Year 2025
B SHENZHEN, China, April 30, 2026 /PRNewswire/ — X Financial (NYSE: XYF) (the “Company” or “we”), a leading online personal finance company in China, today announced… Login to continue reading Login Sign up for complimentary access Sign Up Now Close
Labcorp Announces 2026 First Quarter Results; Raises Full Year 2026 Guidance
B Results from Operations for first quarter 2026 versus first quarter 2025: Revenue: $3.54 billion vs. $3.35 billion, up 5.8% Diluted EPS: $3.35 vs. $2.52,… Login to continue reading Login Sign up for complimentary access Sign Up Now Close
Lilly reports first-quarter 2026 financial results, raises full year guidance, and highlights momentum of new medicines
B Revenue in Q1 2026 increased 56% to $19.8 billion primarily driven by volume growth, partially offset by lower realized prices from Mounjaro and Zepbound.… Login to continue reading Login Sign up for complimentary access Sign Up Now Close
CNX Reports First Quarter Results
B PITTSBURGH, April 30, 2026 /PRNewswire/ — CNX Resources Corporation (NYSE: CNX) (“CNX” or “the company”) today released financial and operational results for the first… Login to continue reading Login Sign up for complimentary access Sign Up Now Close
Immunic to Participate in Investor and Medical Conferences in May
B NEW YORK, April 30, 2026 /PRNewswire/ — Immunic, Inc. (Nasdaq: IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic diseases, today… Login to continue reading Login Sign up for complimentary access Sign Up Now Close
Spin Master Reports Q1 2026 Financial Results and Reiterates 2026 Full Year Outlook
B TORONTO, April 30, 2026 /PRNewswire/ – Spin Master Corp. (“Spin Master” or the “Company”) (TSX: TOY) (www.spinmaster.com), a leading global children’s entertainment company, today… Login to continue reading Login Sign up for complimentary access Sign Up Now Close
